Philip Omotosho1, Alessandro Mor2, Prapimporn Chattranukulchai Shantavasinkul3, Leonor Corsino4, Alfonso Torquati5. 1. Section of Metabolic and Bariatric Surgery, Rush University Medical Center, Rush University, Chicago, IL, USA. 2. Department of Surgery, Duke University, Durham, NC, USA. 3. Division of Nutrition and Biochemical Medicine, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. 4. Division of Endocrinology, Metabolism, and Nutrition, Duke University, Durham, NC, USA. 5. Section of Metabolic and Bariatric Surgery, Rush University Medical Center, Rush University, Chicago, IL, USA. alfonso_torquati@rush.edu.
Abstract
OBJECTIVE: To evaluate the impact of Roux-en-Y gastric bypass (RYGB) on quality of life in obese diabetic patients compared to standard medical therapy for type 2 diabetes mellitus. METHODS: We prospectively studied two matched obese populations with type 2 diabetes. Thirty patients underwent laparoscopic RYGB and 31 received standard medical therapy combined with a diabetes support and education program (DSE), consisting of educational sessions on diet and exercise. Groups were matched by age, gender, weight, glucostatic parameters, and use of glucose-lowering medications (oral agents and insulin therapy). Health-related quality of life (HRQOL) was assessed using the normalized SF-36 questionnaire, and data were collected at baseline and at 12-month follow-up. RESULTS: Diabetic patients who underwent RYGB experienced a statistically significant increase in their overall HRQOL. However, the role-physical and mental health domains increased but did not reach statistical significance. Diabetic patients in the medical therapy and DSE group did not show any significant increase in HRQOL. The between-group differences for the HRQOL changes from baseline were significant, other than for role-physical and mental health domains. Percentage changes in glucostatic parameters, discontinuation of glucose-lowering medications, and T2DM remission were not found to predict the percentage change in SF-36 scores at 12 months after RYGB. CONCLUSIONS: For the first time, with a prospective matched control study, we demonstrate a significant improvement in HRQOL in obese diabetic patients who underwent RYGB, but not in those who were offered standard medical therapy and DSE.
OBJECTIVE: To evaluate the impact of Roux-en-Y gastric bypass (RYGB) on quality of life in obese diabeticpatients compared to standard medical therapy for type 2 diabetes mellitus. METHODS: We prospectively studied two matched obese populations with type 2 diabetes. Thirty patients underwent laparoscopic RYGB and 31 received standard medical therapy combined with a diabetes support and education program (DSE), consisting of educational sessions on diet and exercise. Groups were matched by age, gender, weight, glucostatic parameters, and use of glucose-lowering medications (oral agents and insulin therapy). Health-related quality of life (HRQOL) was assessed using the normalized SF-36 questionnaire, and data were collected at baseline and at 12-month follow-up. RESULTS:Diabeticpatients who underwent RYGB experienced a statistically significant increase in their overall HRQOL. However, the role-physical and mental health domains increased but did not reach statistical significance. Diabeticpatients in the medical therapy and DSE group did not show any significant increase in HRQOL. The between-group differences for the HRQOL changes from baseline were significant, other than for role-physical and mental health domains. Percentage changes in glucostatic parameters, discontinuation of glucose-lowering medications, and T2DM remission were not found to predict the percentage change in SF-36 scores at 12 months after RYGB. CONCLUSIONS: For the first time, with a prospective matched control study, we demonstrate a significant improvement in HRQOL in obese diabeticpatients who underwent RYGB, but not in those who were offered standard medical therapy and DSE.
Entities:
Keywords:
Bariatric surgery; Diabetes; Gastric bypass; Quality of life
Authors: Ali H Mokdad; Earl S Ford; Barbara A Bowman; William H Dietz; Frank Vinicor; Virginia S Bales; James S Marks Journal: JAMA Date: 2003-01-01 Impact factor: 56.272
Authors: Heather K Vincent; Kfir Ben-David; Bryan P Conrad; Kelly M Lamb; Amanda N Seay; Kevin R Vincent Journal: Surg Obes Relat Dis Date: 2012-01-16 Impact factor: 4.734
Authors: Ronette L Kolotkin; Josephine M Norquist; Ross D Crosby; Shailaja Suryawanshi; Pedro J Teixeira; Steven B Heymsfield; Ngozi Erondu; Allison M Nguyen Journal: Health Qual Life Outcomes Date: 2009-06-09 Impact factor: 3.186
Authors: Andrew J Vegel; Neil Shah; Anne O Lidor; Jacob A Greenberg; Ying Shan; Xing Wang; Luke M Funk Journal: J Surg Res Date: 2017-06-15 Impact factor: 2.192
Authors: Piotr Małczak; Magdalena Mizera; Yung Lee; Magdalena Pisarska-Adamczyk; Michał Wysocki; Małgorzata M Bała; Jan Witowski; Mateusz Rubinkiewicz; Alicja Dudek; Tomasz Stefura; Grzegorz Torbicz; Piotr Tylec; Natalia Gajewska; Tanawat Vongsurbchart; Michael Su; Piotr Major; Michał Pędziwiatr Journal: Obes Surg Date: 2021-10-11 Impact factor: 4.129